The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of patients with high-risk nonmetastatic clear cell renal carcinoma in adjuvant therapy trials versus nonclinical trial patients.
 
Jen Hoogenes
No Relationships to Disclose
 
Rodney H. Breau
No Relationships to Disclose
 
Bimal Bhindi
No Relationships to Disclose
 
Ricardo A. Rendon
Stock and Other Ownership Interests - Myovant Sciences
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
 
Simon Tanguay
Honoraria - Pfizer; Roche Canada; Sanofi
Consulting or Advisory Role - BMS; Janssen Oncology; Janssen Oncology; Knight Pharmaceuticals; Merck; Pfizer; Roche Canada; Sanofi
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Johnson & Johnson/Janssen; Medtronic
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Merck; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Tersera
 
Alan So
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen; Tersera
Speakers' Bureau - Janssen
Patents, Royalties, Other Intellectual Property - Patent - SITKA
Expert Testimony - Janssen
 
Luke Lavallee
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen; Knight Pharmaceuticals; Sanofi; Tersera
 
Frederic Pouliot
Stock and Other Ownership Interests - Allogene Therapeutics
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Ferring; Genzyme; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Progenics; Sanofi
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer; Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Patents, Royalties, Other Intellectual Property - Transcriptional system and uses therof for single cell detection
Other Relationship - Merck; Progenics
 
Jean-Baptiste Lattouf
No Relationships to Disclose
 
Lucas W. Dean
Consulting or Advisory Role - Bayer
 
Darrel E Drachenberg
No Relationships to Disclose
 
Lori Wood
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Naveen S. Basappa
Honoraria - Astellas Pharma; Eisai; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Roche Canada
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Aaron Richard Hansen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Merck; Novartis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Neoleukin Therapeutics (Inst); Pfizer/EMD Serono (Inst); Roche/Genentech (Inst)
 
Denis Soulieres
Honoraria - Adlai Nortye; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Adlai Nortye; Ipsen; Merck; Pfizer
Research Funding - Adlai Nortye (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Georg A. Bjarnason
Stock and Other Ownership Interests - Merck
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Merck (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Ranjeeta Mallick
No Relationships to Disclose
 
Anil Kapoor
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)